
Mid-cap stocks are catching investor attention with attractive valuations and strong margins as the interest rate cycle shifts.


US vehicle miles traveled hit a new record, climbing 12% above 2019 levels as hybrid work patterns influence commuting and road congestion.

Utility stocks are currently leading the S&P 500 in 2024, fueled by rising AI-driven power demand and a shift in investor preferences.



Oracle is surging as it pivots toward AI infrastructure, securing major partnerships with cloud rivals and solidifying its position among industry leaders.



New data shows Akeso and Summit's ivonescimab may challenge Merck's top-selling cancer drug, Keytruda. Could this lead to a major industry disruption?

